CD5 immunoreactivity of epithelial cells in thymic carcinoma and CASTLE using paraffin-embedded tissue

American Journal of Clinical Pathology

Volumn 106, Issue 4, 1996, Pages 483-486

  Berezowski, Katherine ^a   Grimes, Margaret M ^a   Gal, Anthony ^b   Kornstein, Michael J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

CD5, CASTLE; Immunohistochemistry; Thymic carcinoma

Indexed keywords

CD5 ANTIGEN; PARAFFIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LUNG CARCINOMA; LYMPHOMA; MALE; MEDIASTINUM TUMOR; PRIORITY JOURNAL; SEMINOMA; THYMOMA; THYMUS CANCER; THYROID CARCINOMA; TUMOR DIFFERENTIATION;

EID: 0029784405     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/106.4.483     Document Type: Article

References (8)

1. Kornstein MJ, Pathology of the Thymus and Mediastinum. Philadelphia: WB Saunders, 1995, pp 94-104.
2. Snover DC, Levine GD, Rosai J. Thymic carcinoma: Five distinctive histological variants. Am J Surg Pathol 1982;6:451-470.
3. Suster S, Rosai J. Thymic carcinoma: A clinicopathologic study of 60 cases. Cancer 1991;67:1025-1032.
4. Hishima T, Fukayama M, Fujisawa M, et al. CD5 expression in thymic carcinoma. Am J Pathol 1994;145:268-275.
5. Chan JKC, Rosai J. Tumors of the neck showing thymic or branchial pouch differentiation: A unifying concept. Hum Pathol 1991;22:349-367.
6. Truong LD, Mody DR, Cagle PT, Jackson-York GL, Schwartz MR, Wheeler TM. Thymic carcinoma: A clinicopathologic study of 13 cases. Am J Surg Pathol 1990;14:151-166.
7. Wick MR, Weiland LH, Scheithauer BW, Bernatz PE. Primary thymic carcinomas. Am J Surg Pathol 1982;6:613-630.
8. Ben-Ezra JM, Kornstein MJ. Antibody NCL-CD5 fails to detect neoplastic CD5+ cells in paraffin sections. Am J Clin Pathol 1996;106:370-373.